SelectQuote Faces Legal Scrutiny Amid DOJ Investigation
SelectQuote Inc. (NYSE: SLQT), a well-known digital insurance platform specializing in Medicare Advantage plans, is currently under intense scrutiny due to a whistleblower lawsuit prompted by the U.S. Department of Justice (DOJ). The lawsuit claims that SelectQuote has engaged in deceptive sales practices, which has resulted in a significant decline in its stock price, plunging nearly 20% in a single day.
Overview of the Allegations
The recent lawsuit, Pahlkotter v. SelectQuote Inc. et al, targets investors who bought shares of SelectQuote from a specific timeframe, namely from September 9, 2020, to May 1, 2025. Allegations within the lawsuit suggest that the company misled investors about its business practices and regulatory compliance.
Kickbacks and Misrepresentation Claims
Central to the complaint is the assertion that SelectQuote misrepresented its sales tactics regarding Medicare Advantage plans. While marketing these services as offering impartial and neutral comparisons, the lawsuit alleges the following:
- Customers were directed to plans that yielded the highest commissions for the company.
- Illegal kickbacks were reportedly accepted in exchange for prioritizing certain plans.
- The company purportedly violated federal laws, including the False Claims Act.
The DOJ claims that from 2016 through at least 2021, SelectQuote was involved in transactions that received improper payments amounting to tens of millions of dollars, while subsequently steering less profitable customers away from more affordable options.
Impact on the Market and SelectQuote's Share Value
The news of the DOJ's involvement has sent ripples throughout the financial markets. SelectQuote's shares have seen a dramatic reduction of over 40% in the last six months, raising alarms among investors regarding the company’s future prospects and its potential reputational fallout.
The Class-Action Lawsuit's Implications
This class-action lawsuit contends that SelectQuote’s public assertions did not adequately reveal critical risks associated with its sales strategies and business model. Consequently, this lack of transparency misled investors, leading them to mistakenly overestimate the firm's growth potential and revenue integrity.
Ongoing Investigation by Hagens Berman
Hagens Berman, the shareholders' rights firm, is meticulously investigating the possibility that SelectQuote engaged in practices that artificially inflated its revenue figures. Reed Kathrein, a partner at the firm, emphasized the seriousness of the situation stating, "The DOJ's involvement elevates this case from a standard business dispute to a significant federal issue. We are probing whether SelectQuote's claim of unbiased advice was merely a façade to cover its kickback-driven sales tactics."
Investors who have experienced significant financial losses or possess information pertinent to this investigation are encouraged to report their experiences.
Understanding Whistleblower Opportunities
Individuals privy to confidential information regarding SelectQuote's operations may want to investigate their options for aiding the investigation or exploring whistleblower avenues. The SEC provides a program that rewards whistleblowers for credible information, potentially offering up to 30% of any monetary recovery.
About Hagens Berman
Hagens Berman is a globally recognized law firm committed to protecting the rights of plaintiffs. They specialize in complex litigations that hold corporations accountable for misconduct, representing investors, whistleblowers, and consumers impacted by corporate negligence. The firm has a notable history of recovering over $2.9 billion in various litigations. More information about their achievements can be found through their professional contact lines.
Frequently Asked Questions
What led to the lawsuit against SelectQuote?
The lawsuit arose following a whistleblower complaint and the DOJ's investigation into SelectQuote's sales practices, alleging deceptive actions and misrepresentation.
Who is eligible to join the class-action lawsuit?
Investors who purchased SelectQuote shares between September 9, 2020, and May 1, 2025, may qualify to participate in the class-action lawsuit.
What are the potential outcomes of this legal situation?
Outcomes could vary, but they may include financial compensation for investors, changes in company practices, or further legal sanctions against SelectQuote.
How can whistleblowers assist in the investigation?
Whistleblowers with relevant non-public information can report their insights, which could potentially lead to significant rewards if their information contributes to a successful enforcement action.
What steps is Hagens Berman taking regarding this case?
The firm is conducting an in-depth investigation into SelectQuote's revenue practices to determine if they were artificially inflated through deceptive tactics.
